RUNX2 and leukemia: Since NPM1 mislocalization is a driver of leukemia, we first examined the subcellular profile of NPM1 across a panel of 9 human myeloid and lymphoid leukemia cell lines (Extended Data Figure 1B, 1C), one of which harbors the NPM1c mutation (OCI-AML3).